The Roots Analysis team is putting in its best effort to offer our clients / readers a reliable source of information, regarding how the pharmaceutical and biotech sectors are coping in the midst of the COVID-19 pandemic. Our intention is to generate realistic insights, based on a variety of factors, which are anticipated to influence both prevalent and future market dynamics. Reach out to us for any help.

Gene Therapies & Associated Vectors: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis)

  • Lowest Price Guaranteed From USD 1,299

  • Published
    April 2022

  • Slides
    131

  • View Count
    319

Example Insights

Gene-Therapies-Associated-Vectors-Intellectual-Property-Landscape-Context-thumb Gene-Therapies-Associated-Vectors-Intellectual-Property-Landscape-Property-Landscape-thumb Gene-Therapies-Associated-Vectors-Intellectual-Property-Landscape-worldwide-thumb Gene-Therapies-Associated-Vectors-Intellectual-Property-Landscape-Search-Expressions-thumb Gene-Therapies-Associated-Vectors-Intellectual-Property-Landscape-Geographies-thumb
Gene-Therapies-Associated-Vectors-Intellectual-Property-Landscape-Associated-Vectors-thumb Gene-Therapies-Associated-Vectors-Intellectual-Property-Landscape-Freedom-to-Operate-thumb Gene-Therapies-Associated-Vectors-Intellectual-Property-Landscape-Valuation-Analysis-thumb Gene-Therapies-Associated-Vectors-Intellectual-Property-Landscape-Claims-Analysis-thumb Gene-Therapies-Associated-Vectors-Intellectual-Property-Landscape-White-Spaces-thumb
Gene-Therapies-Associated-Vectors-Intellectual-Property-Landscape-CPC-Codes-thumb Gene-Therapies-Associated-Vectors-Intellectual-Property-Landscape-Future-Outlook-thumb Gene-Therapies-Associated-Vectors-Intellectual-Property-Landscape-Excel-Deliverable-thumb Gene-Therapies-Associated-Vectors-Intellectual-Property-Landscape-Snapshot-thumb  

 

Overview

Although speculations related to using tailored DNA / RNA sequences to cure genetic disorders were made as early as the 1960s, the first reported use of a gene therapy was in 1990, to treat adenosine deaminase (ADA) deficiency related severe combined immunodeficiency (SCID). Briefly, a replication defective retrovirus was used to transfect autologous T-cells with a functional copy of the ADA gene, which restored normal immune function. The success of the aforementioned regimen spurred several similar attempts over the following years. However, it was the human genome project (1990-2003) that evidently ushered in the era of personalized medicine, turning the tide of treatment for several rare genetic conditions, which were previously considered undruggable. Since then, several gene-targeted therapies have been developed and launched; popular examples include ABECMA™ (Celgene, approved by the US FDA in 2021), BREYANZI (Juno Therapeutics, approved by the US FDA in 2021), SKYSONA™ (bluebird bio, approved by the EC in 2021), TECARTUS™ (Kite Pharma, approved by the US FDA in 2020), and ZOLGENSMA® (Novartis Gene Therapies, approved by the US FDA in 2019). In addition, there are over 1,700 product candidates under development, and close to 40 in the mid to late stages of development (phase II and above), which are anticipated to soon (two to three years) enter the market. Considering the target specificity of such products, many experts believe that this particular segment of modern advanced therapy medicinal products (ATMPs) truly offers the promise of lasting disease remission. 

Although the COVID-19 pandemic limited certain aspects of the wider cell and gene therapies segment of the biopharmaceutical industry, it created significant future opportunities. From the financial perspective, the domain reported strong positive growth, primarily driven by drugs such as ZOLGENSMA®, which reported close to 50% year-on-year growth in 2021. In addition, some innovators, leveraging proprietary technologies, launched COVID-19 directed R&D programs, while others took the opportunity to reposition existing assets in the same direction; either way, industry stakeholders were able to tap into the vast infectious diseases market. Taking into consideration both historical and recent developments, and modern technological advances, it is evident that this upcoming industry segment is at an inflection point. With the rapidly growing success of genetic medicine prompting more innovators to enter the market, the focus is now on building better and more efficacious assets, based on next generation biotechnology platforms. This is likely to pave the way for a much broader wave of new biological interventions. It is, therefore, important to identify key pockets of innovation and areas of improvement, in order to truly innovate whilst maintaining a competitive edge. This report summarizes some of the key R&D trends related to gene therapies and affiliated vectors. It also provides a perspective on the pace and focus of innovation in this field, briefly describing the future of gene therapies as mainstream healthcare solutions.

Scope of the Report

The “Gene Therapies & Associated Vectors: Intellectual Property Landscape” report features an extensive study of some of the key historical and contemporary intellectual property (IP) documents (featuring granted patents, patent applications and other documents) describing gene therapies and affiliated vector constructs. The insights generated in this report have been presented across two deliverables, namely a MS Excel sheet and a MS PowerPoint deck, summarizing the ongoing activity in this domain. Key inclusions are briefly described below:

  • Overall Intellectual Property Landscape

An in-depth review of the various patents and affiliated IP documents that have been published related to the diverse technologies, methods, and compositions associated with the use of genomic data and synthetic DNA / RNA constructs, for therapeutic purposes. It features insights on both historical and recent trends in R&D within this niche.

  • Popular / Relevant Prior Art Search Expressions

An examination of IP literature, shortlisting key words and phrases that have been used to describe gene therapies and associated vector constructs. The analysis includes information on the historical use of the aforementioned terms across different types of IP filings, key affiliated terms (which can be used to further identify similar innovations), and other related trends.

  • Patent Valuation Analysis

A competitive benchmarking and valuation analysis of the IP documents published in this field of innovation, taking into consideration important parameters, such as type of IP document, year of application, time to expiry, number of citations and jurisdiction (factoring in regional GDP).

  • Patentability and Freedom to Operate

A systematic approach to identify relevant areas of innovation by analyzing published IP documents, defining the uniqueness of patented / patent pending innovations, understanding the scope of patentability in this domain, and pinpointing jurisdictions where new and / or modified claims may be filed without infringing on existing IP. 

  • Analysis of Patent Applications

A detailed summary of the patent applications that were filed across different jurisdictions and their relative value in the IP ecosystem. The analysis segregates the intellectual capital in terms of area of innovation and intended applications, thereby, offering the means to understand key areas of research and identify innovation-specific IP filing trends.

  • Analysis of Granted Patents

An elaborate summary of the granted patents across different jurisdictions and their relative value in the IP ecosystem. The analysis also features a meaningful classification system, segregating granted patents into relevant categories to help develop a more detailed perspective on the diverse types of innovations in this domain and their intended applications, and the feasibility for innovators to enter into promising product markets. 

  • Pockets of Innovation and White Spaces

An insightful analysis of the various CPC codes used in published IP literature and their affiliated families, in order to identify historical and existing pockets of innovation (based on the functional area / industry described by the elaborate and systematic system of classifying IP); the analysis also features a discussion on prevalent white spaces (based on CPC symbols) in this arena of research.

  • Claims Analysis

One of the objectives of the report was to analyze and summarize key inferences from the independent claims mentioned in granted, active patents in the dataset. Using a systematic segregation approach, we have analyzed trends associated with [A] the preamble, [B] type of patent (technology patent or method patent), [C] type of claim (open ended claim or closed ended claim) and [D] key elements of a claim (individual aspects of an innovation that are covered in a singular claim).

DELIVERABLE OUTLINES

Excel Deliverable

Sheet 1 features details regarding how the input data for this project was collated, including the search strings used to query a popular patent database (lens.org), and data segregation notes. 

Sheet 2 is a summary MS Excel dashboard, offering a detailed graphical perspective of the intellectual property landscape of gene therapies. It includes pictorial representations of the [A] overall patent landscape, [B] key prior art search expressions, [C] trends related to patent applications (including insights on patentability and freedom to operate), [D] trends related to granted patents (including insights on patentability and freedom to operate), [E] key inferences from a proprietary claims analysis, [F] list of popular CPC symbols (featuring key pockets of innovation), [G] list of popular applicants (shortlisted based on number of published IP documents).

Sheet 3 is an elaborate tabular representation of the overall IP landscape, featuring information on the various patent application- and granted patent-related documents, related to gene therapies, which have been published since 1985. 

Sheet 4 includes a tabular representation of key words and phrases that are used to describe gene therapies and associated vectors.

Sheet 5 is a subset of sheet 3, featuring all the patent applications, covering innovations related to gene therapies and associated vectors.

Sheet 6 is a subset of sheet 3, featuring all the granted patents, covering innovations related to gene therapies and associated vectors. 

Sheet 7 is an insightful summary of key inferences from the independent claims mentioned in the granted, active patents in the dataset. We have used a systematic segregation approach to analyze trends associated with the preamble, type of patent (technology patent or method patent), type of claim (open ended claim or closed ended claim) and key elements of a claim (individual aspects of an innovation that are covered in a singular claim).

Sheet 8 provides insights related to some of the key applicants in this field of research, featuring company-specific details (such as year of establishment, and location of headquarters), and inputs on their respective IP publication trends. 

Sheet 9 features an analysis of the most popular CPC symbols and CPC families(in terms of frequency of appearance in the dataset), related to the diverse applications of gene therapies and associated vectors in the treatment of different clinical conditions with a genetic cause.     

Sheet 10 is an appendix which includes pivot tables that drive the charts and interactive elements for the complete IP landscape, in sheet 2.

Sheet 11 is an appendix, featuring details related to the categorization done in the report, and important abbreviations used in reference to the data categories mentioned in the document. 

PowerPoint Deliverable
Chapter 1 briefly describes of the need for targeted and more efficacious therapeutic interventions, and the key advantages of gene therapies. Further, it provides an overview of the intellectual property landscape related to gene therapies (including certain types of cell therapies and associated vector constructs). 

Chapter 2 and 3 feature brief (pictorial) summaries of the approach used for data collection and the key objectives of the study.

Chapter 4 features an executive summary of the key insights generated from analyzing the intellectual property landscape of gene therapies and associated vectors.

Chapter 5 features a brief description of gene therapies and offers an informed perspective on the contemporary need for targeted and efficacious therapeutic solutions, in the treatment of clinical conditions that are characterized by a genetic cause; this includes oncological disorders, several metabolomic and degenerative diseases, and close to 40% of rare diseases. It provides an impactful summary of the important milestones in this field of research and highlights some of the distinguishing features of both early generation and modern variants of these personalized therapies. It also includes a list of important focus areas (in terms of innovation) and key areas of application. Finally, the chapter describes the various advantages of gene therapies and highlights existing limitations.

Chapter 6 includes a review of the various patents and IP documents that have been published related to technologies and methods associated with gene therapies and associated vectors, featuring insights related to both historical and recent trends.

Chapter 7 features an insightful examination of IP literature, highlighting key words and phrases that are used to describe gene therapies and associated vectors, including information on historical usage in IP filings, key affiliated terms (which can be used to further identify similar innovations), and other related trends.

Chapter 8 offers insights from a competitive benchmarking and valuation analysis of the IP documents published related to this field of research, taking into account important parameters, such as type of IP document, year of application, time to expiry, number of citations and jurisdiction (factoring in regional GDP).

Chapter 9 provides a detailed summary of the patent applications that were filed across different jurisdictions and their relative value in the IP ecosystem. The analysis segregates the intellectual capital in terms of area of innovation and intended applications, thereby, offering the means to understand key areas of research and identify innovation-specific IP filing trends. Based on a systematic approach, the chapter highlights relevant areas of innovation from a deeper analysis of published IP documents, defining the uniqueness of patent pending innovations, understanding the scope of patentability in this domain, and pinpointing jurisdictions where new and / or modified claims may be filed without infringing on existing IP.

Chapter 10 is an elaborate summary of the granted patents across different jurisdictions and their relative value in the IP ecosystem. The analysis uses a proprietary segregation criterion, based on type of product / solution and intended applications; this offers the means to identify unique innovations that presently have marketing exclusivity and explore future opportunities to enter into promising product markets, once their patents expire. Based on a systematic approach, the chapter highlights relevant areas of innovation from a deeper analysis of published IP documents, defining the uniqueness of patented innovations, understanding the scope of patentability in this domain, and pinpointing jurisdictions where new and / or modified claims may be filed without infringing on existing IP.

Chapter 11 features profiles of some of the most popular applicant companies, which were shortlisted based on patent filing activity. Each profiles includes, a brief overview of the company, information on annual revenues (wherever available), details of its initiatives focused on the healthcare sector, names of key management team members and recent developments. 

Chapter 12 includes an insightful analysis of the various CPC symbols mentioned in the published IP literature and their affiliated families, in order to identify historical and existing pockets of innovation (based on the functional area / industry described by the elaborate and systematic system of classifying IP); the analysis also features a discussion on the prevalent white spaces (based on CPC symbols) in this area of research.

Chapter 13 concludes the report by providing insights on anticipated developments in this domain (from the perspective of eminent industry representatives of stakeholders in this domain), and trends that are likely to shape the future of the gene therapies market. 

Chapter 14 is a set of appendices.

Contents

Table Of Contents

Excel Deliverable 
1. Research Notes

2. Summary Dashboard
A. Overall Intellectual Property Landscape
B Key Prior Art Search Expressions
C. Key Trends related to Patent Applications (featuring Patentability & Freedom to Operate)
D. Key Trends related to Granted Patents (featuring Patentability & Freedom to Operate)
E. Claims Analysis
F. Key CPC Symbols
G. Key Applicants

3. Overall Intellectual Property Landscape Dataset

4. Prior Art Search Expressions (Keyword Analysis)

5. Patent Applications Dataset

6. Granted Patents Dataset

7. Claims Analysis

8. Key Applicants Analysis

9. CPC Analysis

10. Appendix I: Pivot Tables

11. Appendix II: Country / Geography Codes

12. Appendix III: Innovation Categories

PowerPoint Deliverable 
1. Context

2. Project Approach

3. Project Objectives

4. Executive Summary

5. Gene Therapies and Associated Vectors
5.1. Overview
5.2. Need for Targeted Therapies (Expert Opinion)
5.3. Gene Therapy Development Timeline
5.4. Early Gene Therapies
5.5. Modern Gene Therapies
5.6. Current Focus of Innovation & Key Application Areas
5.7. Key Advantages and Limitations

6. Overall Intellectual Property Landscape
6.1. Overview
6.2. Analysis of Published IP Documents
6.3. Insights from Patent Applications
6.4. Insights from Granted Patents

7. Key Prior Art Search Expressions
7.1. Overview
7.2. Analysis of Prior Art Search Expressions

8. Intellectual Property Valuation Analysis
8.1. Valuation Overview
8.2. Analysis of Individual Value Ranks
8.2.1. Rank 1 IP Documents
8.2.2. Rank 2 IP Documents
8.2.3. Rank 3 IP Documents
8.2.4. Rank 4 IP Documents
8.2.5. Rank 5 IP Documents
8.3. Concluding Remarks

9. Analysis of Patent Applications
9.1. Overview
9.2. Relative Valuation of Patent Applications
9.3. Patentability & Freedom-to-Operate

10. Analysis of Granted Patents
10.1. Overview
10.2. Relative Valuation of Grated Patents
10.3. Patentability & Freedom-to-Operate
10.4. Analysis of Patent Claims

11. Key Applicants
11.1. Overview
11.2. Analysis of Key Applicants
11.2.1. Company A
11.2.2. Company B
11.2.3. Company C
11.2.4. Company D
11.2.5. Company E
11.2.6. Company F
11.2.7. Company G
11.2.8. Company H
11.2.9. Company I
11.2.10. Company J

12. Pockets of Innovation and White Spaces
12.1. Overview
12.2. Pockets of Innovation
12.3. White Spaces
12.4. Concluding Remarks

13. Future Outlook
14.1. Overview
14.2. Contemporary Sentiments & Expert Opinions
14.3. Key Developments since the COVID-19 Pandemic
14.4. Future Tipping Points in Gene Therapy
14.5. Anticipated Future Developments & Trends

14. Appendices

List Of Companies

The following companies / institutes / government bodies and organizations have been mentioned in this report.

  1. 20/20 GeneSystems
  2. Aarhus University
  3. Aav Gene Therapeutics
  4. Abbott
  5. Abeona Therapeutics
  6. Abic 
  7. Abiomed
  8. Abrev Biotechnology
  9. Acambis
  10. Access Biologics
  11. ACGT
  12. Acuitas Therapeutics
  13. Adagene
  14. Adaptimmune 
  15. Adrenas Therapeutics
  16. Advanced Tissue Sciences
  17. Advanced Vision Therapies
  18. Advantagene
  19. Advaxis
  20. Advec
  21. Adverum Biotechnologies
  22. Advisys
  23. Aegera Therapeutics
  24. Affymetrix
  25. Agency for Science and Technology Research
  26. Agenovir
  27. Agenta Biotechnologies
  28. Agenus
  29. Agouron Pharmaceuticals
  30. Ajou University
  31. Akouos
  32. Albert Einstein College of Medicine
  33. Alcon
  34. Aleta Biotherapeutics
  35. Alexion Pharma
  36. Alkermes
  37. All India Institute of Medical Sciences
  38. Allogene Therapeutics
  39. Alnylam Pharmaceuticals
  40. AlphaCore Pharma
  41. Alpharma
  42. AlphaVax
  43. Alpine Immune Sciences
  44. Alsatech
  45. Altimmune
  46. Altius Institute for Biomedical Sciences
  47. Alza
  48. Amaxa
  49. Amedeo Avogadro University of Eastern Piedmont
  50. American Biosciences
  51. American Gene Technologies International
  52. Amgen
  53. Amicus Therapeutics
  54. AmpliPhi Biosciences
  55. Amrad Operations
  56. Amryt Pharma
  57. Andaris
  58. AnGes
  59. Angiocrine Bioscience
  60. Angiogene Pharmaceuticals
  61. Ansun Biopharma
  62. Anthrogenesis
  63. AntiCancer
  64. Antigen Express
  65. Apceth Biopharma
  66. Apellis Pharmaceuticals
  67. Apoptosis Technology
  68. Applied Biotechnology
  69. Applied Genetic Technologies Corporation
  70. Applied Genetic Technology Corporation
  71. Applied Research Solutions
  72. Apres Therapeutics
  73. Araid Pharmaceuticals
  74. Arbor Biotechnologies
  75. Arcturus Therapeutics
  76. Arecor Therapeutics
  77. Ariad Pharma
  78. Arizeke Pharmaceuticals
  79. Ark Therapeutics
  80. Aronex Pharmaceuticals
  81. Artemis Pharmaceuticals
  82. Asklepios Biopharmaceutical (AskBio)
  83. Astellas Pharma
  84. AstraZeneca
  85. Asuragen
  86. Atara Biotherapeutics
  87. Auburn University
  88. Auckland Uniservices
  89. Audentes Therapeutics
  90. Autolus
  91. Auxolytic
  92. Avalanche Australia
  93. Aventis Pharma
  94. Avigen
  95. AviGenics
  96. Avior Bio
  97. AVIR Green Hills Biotechnology
  98. Avrobio
  99. AxioMx
  100. Axovant Sciences
  101. Azienda Ospedaliera Universitaria Senese (AOUS)
  102. Bamboo Therapeutics
  103. BASF
  104. Bavarian Nordic
  105. Baxalta
  106. Baxter International
  107. Bayer
  108. BDgene
  109. Beam Therapeutics
  110. Behringwerke
  111. Beijing Bio Targeting Therapeutics Technology
  112. Beijing Marino Biotechnology
  113. Beijing Meikang Geno Immune Biotechnology
  114. Beijing SBS Genetech
  115. Beijing Shuangyin Biotechnology
  116. Belief Biomed
  117. Bellicum Pharmaceuticals
  118. Ben-Gurion University of the Negev
  119. Benitec Biopharma
  120. Beth Israel Deaconess Medical Center
  121. Biocache Pharmaceuticals
  122. Bio-D
  123. Biogen
  124. BioInnovations
  125. BioMarin Pharmaceuticals
  126. Biomirna Holdings
  127. Bioneer
  128. Bionomics
  129. BioNTech Innovative Manufacturing Services
  130. Bioray Laboratories
  131. Biorchestra
  132. Biosense
  133. Biosource Genetics
  134. Biosource Technology
  135. Biosphere Medical
  136. BioStratum
  137. Biotechnology Research
  138. BioTransplant
  139. Bioverativ Therapeutics
  140. BioVex
  141. BioViva
  142. Bluebird Bio
  143. Boehringer Ingelheim
  144. Boehringer Mannheim
  145. Boston Medical Center
  146. Boston Scientific
  147. Boston University
  148. Brainvta Wuhan
  149. Brandeis University
  150. BresaGen
  151. Brigham and Women's Hospital
  152. British Columbia Cancer Agency
  153. Broad Institute
  154. Brown University Research Foundation
  155. Brunel University London
  156. Cafa Therapeutics
  157. Caladrius Biosciences
  158. California Institute of Technology
  159. Calimmune
  160. Calydon
  161. Cambridge Enterprise
  162. Cancer Research Technology
  163. Canji
  164. CanSino Biologics
  165. Cantab Biopharmaceuticals
  166. Capital University of Medicine
  167. Cardiff University
  168. Cardium Therapeutics
  169. Carestream Health
  170. Carina Biotech
  171. Carisma Therapeutics
  172. Carmel Haifa University Economic Corporation
  173. Carnegie Institute for Science
  174. Carnegie Venture Capital
  175. Carsgen Therapeutics
  176. Case Western Reserve University
  177. Catalan Institution for Research and Advanced Studies
  178. Catalent Pharma Solutions
  179. Catalyst Biosciences
  180. Celgene
  181. Cell & Brain
  182. Cell and Gene Therapy
  183. Cell Care Therapeutics
  184. Cell Genesys
  185. Cell Medica Switzerland
  186. Celladon
  187. CellCentric
  188. CellGenTech
  189. Cellinbio
  190. Cell-Medicine
  191. Celltech Therapeutics
  192. Cellular Biomedicine Group
  193. Cellular Dynamics International
  194. Cellular Therapeutics
  195. Centenary Institute for Cancer Medicine and Cell Biology
  196. Centre Hospitalier de l’Université Laval (CHUL) Research Centre
  197. Ceregene
  198. CERo Therapeutics
  199. CG Oncology
  200. Chameleon Biosciences
  201. Chan Zuckerberg Biohub
  202. Chemokine Therapeutics
  203. Chengdu Youwa Biotechnology
  204. Children's Healthcare of Atlanta
  205. Children's National Hospital
  206. China Agricultural University
  207. China Medical University
  208. China Pharmaceutical University
  209. Chiron
  210. CHO Pharma
  211. ChromaXome
  212. Chromos Molecular Systems
  213. CHS Pharma
  214. Chugai Pharmaceutical
  215. Chungbuk National University
  216. Chungnam National University
  217. Ciba-Geigy
  218. Circuit Therapeutics
  219. Citagenix
  220. Claude Bernard University Lyon 1
  221. Clear Solutions Biotech
  222. Clearside Biomedical
  223. CLS Therapeutics
  224. CMIC Holdings
  225. CNIC - Spanish National Center for Cardiovascular Research
  226. Cobra Biologics
  227. CODA Biotherapeutics
  228. Codexis
  229. Codiak Biosciences
  230. Cogent Biosciences
  231. Cogent Neuroscience
  232. Coley Pharmaceutical Group
  233. Coley Pharmaceuticals
  234. Collaborative Lab
  235. Collateral Therapeutics
  236. College of Medicine Pochon Cha University Industry -Academic Cooperation Foundation
  237. Columbia University 
  238. Combined Therapeutics
  239. Copernicus Therapeutics
  240. Corestem
  241. Coretecs
  242. Corixa
  243. Cornell Research Foundation
  244. Cornell University
  245. Côte d'Azur University
  246. Council of the Queensland Institute of Medical Research
  247. Creighton University
  248. CRISPR Therapeutics
  249. Crusade Laboratories
  250. CSL Behring
  251. CSL Gene Therapy
  252. Cue Biopharma
  253. Curamys
  254. CureVac
  255. Curocell
  256. Cyto Pulse Sciences
  257. Cytogen
  258. Cytoimmune Therapeutics
  259. Cytos Biotechnology
  260. CytoTherapeutics
  261. CytRx
  262. Daegu Institute of Science and Technology
  263. Daiichi Asubio Pharma
  264. Daiichi Sankyo
  265. Dalian Minzu University
  266. Dana Farber Cancer Institute
  267. Dankook University
  268. DaRen
  269. Darwin Molecular
  270. Decibel Therapeutics
  271. Defyrus
  272. DeNovix
  273. Dept Of Biotechnology
  274. Diadexus
  275. Digital Gene Technologies
  276. Discovery Genomics
  277. Distributed Bio
  278. DNA Twopointo
  279. DNA2.0
  280. DNAVEC Research
  281. DRK-Blutspendedienst Baden-Württemberg-Hessen gemeinnützige 
  282. Duke University
  283. Dyax
  284. East China Normal University
  285. East China University of Science and Technology
  286. EdiGene
  287. Editas Medicine
  288. Edwards Lifesciences
  289. Egen
  290. Eiger Biopharmaceuticals
  291. Eisai
  292. Elan Pharmaceuticals
  293. Elbio
  294. Elim Biopharmaceuticals
  295. Elixirgen Therapeutics
  296. Emerald Gene Systems
  297. Emory University
  298. Enanta Pharmaceuticals
  299. Encoded Therapeutics
  300. Encodegen
  301. Endocyte
  302. Endorecherche
  303. enGene
  304. Engeneic Molecular Delivery 
  305. EnhancedBio
  306. Enzo Therapeutics
  307. Enzon Pharmaceuticals
  308. Eötvös Loránd University
  309. Epeius Biotechnologies
  310. Erasmus University Medical Center 
  311. Erytech Pharma
  312. Esteve Pharmaceuticals
  313. Ethicon
  314. Etubics
  315. Evolva
  316. Evotech Biosystems
  317. Evox Therapeutics
  318. Excision BioTherapeutics
  319. Exemplar
  320. Exhaura
  321. Exonics Therapeutics
  322. Exuma Biotech
  323. Factor Bioscience
  324. Falcon Therapeutics
  325. Fantasia Biopharma Zhejiang 
  326. Fate Therapeutics
  327. Feldan Therapeutics
  328. Finnish Immunotechnology
  329. FinVector
  330. Five Prime Therapeutics
  331. Flagship Pioneering Innovations
  332. FloDesign Sonics
  333. Florida Atlantic University
  334. Fondazione Cariplo
  335. Forhumantech 
  336. Forschungszentrum Jülich
  337. Fortgen Tech 
  338. Fortis Therapeutics
  339. Fortunebio
  340. Freeline Therapeutics
  341. Friedrich Miescher Institute of Biomedical Research
  342. Friedrich–Alexander University Erlangen–Nürnberg
  343. Fujifilm Cellular Dynamics
  344. Fulcrum Therapeutics
  345. Fundação Edson Queiroz - Universidade de Fortaleza
  346. Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP)
  347. Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús
  348. Fuso Pharmaceutical
  349. Fziomed
  350. G&P Bioscience 
  351. Gachon University
  352. Ganymed Pharmaceuticals
  353. Garelag
  354. Gavish-Galilee Bio Applications
  355. GC Pharma
  356. GE Healthcare Dharmacon 
  357. GE Healthcare Systems
  358. Geistlich Holding
  359. Gemini Therapeutics
  360. Genascence
  361. Gencia
  362. Gene Bridges
  363. Gene Logic
  364. Gene Medicine
  365. Gene Therapy Research Institution
  366. GeneArt
  367. Genelux
  368. Genemedicine
  369. Genena
  370. Genentech
  371. GeneProTech
  372. Generoath
  373. GeneSense Technologies
  374. Genethon
  375. Genetic Diagnostics and Therapy 21
  376. Genetix Pharmaceuticals
  377. Geneuin Technology
  378. Genizon Biosciences
  379. Genotherapeutics
  380. Genovo
  381. GenScript Biotech
  382. GenStar Therapeutics
  383. GenVec
  384. Genzyme
  385. Georg-August-University of Goettingen
  386. Georgetown University
  387. GeoVax
  388. Geron
  389. Ghent University
  390. Gilead Sciences
  391. Glaxo Smith Kline (GSK)
  392. Global BioTherapeutics
  393. GlobeImmune
  394. Goleini
  395. GPC Biotech
  396. Gracell Biotechnologies
  397. Gradalis
  398. Greatbatch Medical
  399. Greffex
  400. Gritstone Bio
  401. Grünenthal
  402. Guangdong Tcrcure Biopharma Technology
  403. Guangdong Xiangxue Life Sciences
  404. Guangzhou Heershi Pharma Development
  405. Guangzhou Huazhen Pharmaceutical
  406. Guangzhou N Biomed
  407. Guangzhou Virotech Pharmaceutical
  408. Gustave Roussy
  409. Gwangju Institute of Science and Technology
  410. Gyeongsang National University
  411. Gyroscope Therapeutics
  412. Haldane Research
  413. Hanall Pharmaceuticals
  414. HanX Biopharmaceuticals
  415. Hanyang University
  416. Hav Vaccines
  417. Health and Social Care Research & Development
  418. Health Protection Agency
  419. Health Research
  420. Heart Biosystems
  421. Helixmith
  422. Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
  423. Hepatix
  424. HepaVec 
  425. Hera Testing Laboratories
  426. Hisamitsu Pharmaceutical
  427. Hoechst
  428. Homology Medicines
  429. Hookipa Biotech
  430. Horizon Discovery
  431. Hormos Medical
  432. HSC Research and Development
  433. HSF Pharmaceuticals
  434. Human Genome Sciences
  435. Humanigen
  436. Humanzyme
  437. Hunan University of Chinese Medicine
  438. Hyal Pharmaceutical
  439. Hybrid Biosystems
  440. Ich Productions
  441. Icon Genetics
  442. ID Pharma
  443. Idera Pharmaceuticals
  444. Imagine Institue of Genetic Diseases Necker Sick Children Foundation
  445. ImaRx Pharmaceutical
  446. ImClone Systems
  447. Immatics Us
  448. Immetas Therapeutics
  449. Immune Design
  450. ImmunityBio
  451. Immunoclin
  452. ImmunoGen
  453. Immunomedics
  454. Immusoft
  455. Immusol
  456. Immvira
  457. Imperial College Innovations
  458. Inari Agriculture
  459. Incell: Innovative Life Science Solutions
  460. Indiana University
  461. Indoor Biotechnologies
  462. Ingenium Pharmaceuticals
  463. INmune Bio
  464. Innopeutics
  465. InnoTherapy
  466. Innovative Cellular Therapeutics
  467. Innovir Laboratories
  468. Inovio Pharmaceuticals
  469. Inozyme Pharma
  470. Inscripta
  471. InsideOutBio
  472. InSite Vision
  473. Institut National de La Rech Agronomique (INRA)
  474. Institute Neue Mat Gemein
  475. Institute of Cytosignal Research
  476. Institute of Oncology Ljubljana
  477. Intellia Therapeutics
  478. International healthcare center, Seoul National University Hospital
  479. Intima Bioscience
  480. Intracell Therapeutics
  481. Intradigm
  482. Intrexon
  483. Introgen Research Institute
  484. Introgen Therapeutics
  485. Intronn
  486. Invitrogen
  487. Ionis Pharmaceuticals
  488. IRCCS Ca 'Granda Foundation Maggiore Policlinico Hospital
  489. Island Pharmaceuticals
  490. Isogenis
  491. IVexSol
  492. Janssen Biotech
  493. Janssen Pharmaceuticals
  494. Japan Research and Development
  495. Japan Science & Technology Agency
  496. Japan Tissue Engineering
  497. Japan Weight Management
  498. Japanese Foundation For Cancer Research
  499. Jenapharm
  500. Jichi Medical University
  501. Johnson & Johnson
  502. Joslin Diabetes Center
  503. Juno Therapeutics
  504. Junten Bio
  505. Juventas Therapeutics
  506. Kagoshima University
  507. Kang Stem Biotech
  508. Kanglin Biotechnology Hangzhou
  509. KAUST: King Abdullah University of Science and Technology
  510. Keio University
  511. Kennedy Krieger Institute
  512. Kinetic Concepts
  513. King & Company
  514. Kite Pharma
  515. Knoll Pharmaceuticals
  516. Kojima Industries
  517. Kolon Industries
  518. Kolon Life Science
  519. Kolon TissueGene
  520. Korea Advanced Institute of Science and Technology
  521. Korea Institute of Radiology and Medical Science
  522. Korea Institute of Science and Technology
  523. Korea Research Institute of Bioscience
  524. KOS Pharmaceuticals
  525. KTB Tumorforschungs
  526. KU Leuven Research & Development
  527. Kudos Pharmaceuticals
  528. Kurume University
  529. Kyoto University
  530. La Jolla Institute for Immunology
  531. Lacerta Therapeutics
  532. Lancea Therapeutics
  533. Large Scale Biology
  534. L'Association Institut de Myologie
  535. Laurantis Pharma
  536. Laval University
  537. Le Centre hospitalier universitaire (CHU) de Nantes 
  538. Le Centre Hospitalier Universitaire de Toulouse
  539. LegoChem Biosciences
  540. Leiden University
  541. Leiden University Medical Center (LUMC)
  542. Leidos
  543. Leipzig University
  544. Lentigen
  545. Leukocare
  546. Levicept
  547. Lexicon Pharmaceuticals
  548. Licentia
  549. Life Technologies
  550. Lions Eye Institute
  551. LocanaBio
  552. Loeb Health Research Institute at the Ottawa Hospital
  553. LogicBio Therapeutics
  554. Lokon Pharma
  555. Loma Linda University
  556. Lonza
  557. Lorus Therapeutics
  558. Louisiana State University
  559. Loxegen
  560. Ludvig Institute of Cancer Research
  561. Ludwig Maximilian University of Munich
  562. Lung Biotechnology
  563. L'Université Clermont Auvergne ( UCA )
  564. Maastricht University
  565. Maavrx
  566. Macfarlane Burnet Institute for Medical Research and Public Health
  567. Macfarlane Burnet Institute for Medicine
  568. Macquarie University
  569. Magenta Therapeutics
  570. Magnum Therapeutics
  571. Mandom
  572. Martin Luther University of Halle-Wittenberg
  573. Massachusetts General Hospital
  574. Massachusetts Institute of Technology
  575. Maxygen
  576. McGill University
  577. McLean Hospital
  578. McMaster University
  579. Medgene Bioscience
  580. Medgenics Medical
  581. Medical Research Council
  582. MediGene
  583. Medimmune
  584. Medinet
  585. Medipost
  586. Meditech Research
  587. Medtronic
  588. MeiraGTX
  589. Mercator Genetics
  590. Merck
  591. Merial
  592. Mesoblast
  593. Metacine
  594. MGenbio
  595. Michigan State University (MSU)
  596. Micromet
  597. Millennium Pharmaceuticals
  598. MilliporeSigma
  599. Miltenyi Biotec
  600. Mindset BioPharmaceuticals
  601. Minerva Biotechnologies
  602. Minitüb Abfüll- und Labortechnik
  603. Miragen Therapeutics
  604. Mirexus Biotechnologies
  605. Mirus Bio
  606. Mitsubishi Tanabe Pharma
  607. Mochida Pharmaceutical
  608. Modalis Therapeutics
  609. Mologen
  610. Monash University Malaysia
  611. Monsanto Technology
  612. Montpellier 2 University
  613. Morphogenesis
  614. Motac Neuroscience
  615. MSD Animal Health
  616. MultiGene Biotech
  617. MultiVir
  618. MUSC Foundation for Research Development
  619. MyDOPA
  620. Myeloid Therapeutics
  621. Myelos
  622. Myriad Genetics
  623. Nagoya Industrial Science Research Institute
  624. Nanjing Legend Biotech
  625. Nanodoc
  626. NantBioscience
  627. Nantcell
  628. National Institute of Advanced Studies
  629. National Institute of Allergy and Infectious Disease
  630. National Institute of Higher Education and Research in Food, Animal Health, Agronomic and Environmental Sciences
  631. National Institute of Radiology
  632. National University Corporation Chiba University
  633. NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY
  634. National University Corporation Kyushu University
  635. National University Corporation, Gunma University
  636. National University Corporation, Hokkaido University
  637. National Yang Ming Chiao Tung University
  638. Nature Technology
  639. Ncc Technology Ventures
  640. Neoclone Biotechnology
  641. NeoX
  642. Netherlands Cancer Institute
  643. Netherlands Institute for Neuroscience
  644. Neumedicines
  645. Neuren Pharmaceuticals
  646. Neurogenex
  647. NeuroLogix
  648. Neurome
  649. Neurona Therapeutics
  650. Neurophth
  651. Neurotech USA
  652. Neutrolis
  653. New York Blood Center (NYBC)
  654. New York University
  655. Newcastle University
  656. NewLink Genetics
  657. NewSouth Innovations
  658. NGM Biopharmaceuticals
  659. NightstaRX
  660. Nordic Nanovector
  661. Northeast Ohio Medical University
  662. Northern Therapeutics
  663. NorthShore University HealthSystem
  664. Northwestern University
  665. Norwegian University of Science and Technology
  666. Nouscom
  667. Novartis
  668. Novogene
  669. Novopyxis
  670. NTF Therapeutics
  671. NTNU Technology Transfer
  672. NxGen Medicine
  673. NYU Grossman School of Medicine
  674. Obsidian Therapeutics
  675. Octane Biotech
  676. Ocugen
  677. Ohio University 
  678. Oisin Biotechnologies
  679. Okairos
  680. Old Dominion University
  681. Ology Bioservices
  682. Omega Therapeutics
  683. OmniSpirant Therapeutics
  684. Oncolytics Biotech
  685. Onconetics Pharmaceuticals
  686. Oncormed
  687. Oncorus
  688. OncoSec Medical
  689. ONL Therapeutics
  690. Onyx Pharma
  691. Optigen Patents
  692. Orchard Therapeutics
  693. Oregon Health & Science University
  694. Orgenesis
  695. Ortho Pharma
  696. Orthobio Therapeutics
  697. Osaka University 
  698. Oslo University Hospital
  699. Otonomy
  700. Otsuka Pharmaceuticals
  701. Ottawa Hospital Research Institute
  702. Ovid Therapeutics
  703. Oxford University Innovation
  704. OxfordBiomedica
  705. Oxgene
  706. Oxxon Therapeutics
  707. Oxyrane
  708. Pact Pharma
  709. Paris Descartes University
  710. Paris Diderot University
  711. Paris-Saclay University
  712. Paris-Sud University
  713. Paros Bio
  714. Parvogen International
  715. Paul Sabatier University
  716. Peking University
  717. PeptiMed
  718. Pfizer
  719. Pharchoice Therapeutics
  720. Pharis Biotec
  721. Pharmaceutical Patent Attorneys
  722. Pharmacia & Upjohn
  723. PharmaSpec
  724. Pharmexa
  725. Pherin Pharmaceuticals
  726. Phi Biomed
  727. Pierre and Marie Curie University
  728. Pillargo
  729. PlasmidFactory
  730. Pohang University of Science and Technology (POSTECH)
  731. PolyMASC Pharmaceuticals
  732. Poseida Therapeutics
  733. PowderJect Pharmaceuticals
  734. PPL Therapeutics
  735. Precigen
  736. Precision Biosciences
  737. Precision Bioservices
  738. Precision Nanosystems
  739. Prevail Therapeutics
  740. Primmune Therapeutics
  741. Princeton University
  742. Prizm Pharma
  743. ProBioGen
  744. ProCell Therapeutics
  745. Profectus Biosciences
  746. Prostemics
  747. Provention Bio
  748. PsiOxus Therapeutics
  749. PTC Therapeutics
  750. Purdue Research Foundation
  751. Puridify
  752. Qiagen
  753. Quadrant Healthcare
  754. Quark Pharmaceuticals
  755. Quarrymen & Co
  756. Queen Mary University of London
  757. Queen's University at Kingston
  758. Quell Therapeutics
  759. Quethera
  760. Quuensland Institute of Medical Research
  761. Radboud University Nijmegen
  762. Ramot at Tel Aviv University
  763. ReflectionBio
  764. Regeneron
  765. Regenxbio
  766. ReNeuron
  767. Renishaw
  768. Renovo
  769. Repair Biotechnologies
  770. Repligen
  771. Rescue Hearing
  772. Research Corporation Technologies
  773. Resverlogix
  774. Reyon Pharmaceutical
  775. RheoGene
  776. Ribo Life Science
  777. Ribozyme Pharmaceuticals
  778. Richland Bio Medical
  779. Riken
  780. Roche
  781. Rocket Pharmaceuticals
  782. RootPath Genomics
  783. Rowan University
  784. Rubicon Labs
  785. RUBITEC Gesellschaft für Innovation und Technologie der Ruhr-Universität Bochum
  786. Rubius Therapeutics
  787. Rudacure
  788. Ruijin Hospital Affiliated To Shanghai Jiaotong University
  789. Ruprecht-Karls-Universität Heidelberg
  790. Rush University Medical Center 
  791. Rutgers New Jersey Medical School
  792. Rutgers, the State University of New Jersey
  793. Safescience
  794. Saint Louis University (SLU)
  795. Saint-Gobain Performance Plastics
  796. Salk Institue for Biological Studies
  797. Salus University
  798. Samsung Life Public Welfare Foundation 
  799. Samyang
  800. Samyang Genex
  801. Sana Biotechnology
  802. Sandoz
  803. Sangamo Therapeutics
  804. Sanofi Pasteur
  805. Sarepta Therapeutics
  806. Sbarro Health Research Organistaion
  807. Schepens Eye Research Institute
  808. Schering
  809. Schering-Plough
  810. Scholar Rock
  811. Selecta Biosciences
  812. Selective Genetics
  813. Sementis
  814. Senti Biosciences
  815. Seoul National University R&DB Foundation
  816. Seoul National University R&DB Research Foundation
  817. Serenity Bioworks
  818. Shanghai Cell Therapy Group
  819. Shanghai Innostellar Biotherapeutics
  820. Shanghai Jiao Tong University
  821. ShanghaiTech University
  822. Shape Therapeutics
  823. Shenzhen Mindray Bio-Medical Electronics
  824. Sichuan University
  825. SiDanSai Biotechnology
  826. Sigilon Therapeutics
  827. Sirion Biotech
  828. Sirnaomics
  829. SIT Biotech
  830. SIT-Soft Intelligent Therapeutics
  831. Snipr Biome
  832. Soft Gene
  833. Solid Biosciences
  834. Solvo Biotechnology
  835. Somatix Therapy
  836. Somatogen
  837. Soochow University
  838. Sorbonne University
  839. Southeast University
  840. Spark Therapeutics
  841. Spiber
  842. SpyBiotech
  843. St. Jude Children's Research Hospital
  844. St. Vincent's Hospital Sydney
  845. Stabilitech Biopharma
  846. Staidson Beijing Biopharmaceuticals
  847. Stanford University
  848. Stem Cell Australia
  849. Stemline Therapeutics
  850. Stemron
  851. Stichting Katholieke Universiteit (SKU)
  852. Stoke Therapeutics
  853. Stressgen Biotechnologies
  854. StrideBio
  855. Strike Bio
  856. Stryker
  857. Sumitomo Dainippon Pharma 
  858. Supratek Pharma
  859. SwanBio Therapeutics
  860. Switch Biotech
  861. Sygnis Bioscience
  862. Symbigene
  863. Synageva
  864. Synedgen
  865. Synergen Bio
  866. SynerGene Therapeutics
  867. SynGenix
  868. Syno Minicircle Biotechnology
  869. Synpromics
  870. Synthego
  871. SYStemix
  872. Takara Bio
  873. Takeda
  874. Tallinn University of Technology
  875. Tanox
  876. Targetech
  877. TCR2 Therapeutics
  878. TCRCure Biopharma
  879. Technion Research & Development
  880. Techno Network Shikoku
  881. Teikyo University
  882. Tel Hashomer Medical Research Infrastructure & Services
  883. Temple University
  884. Tenaya Therapeutics
  885. TET Systems
  886. TG Therapeutics
  887. The Abigail Wexner Research Institute at Nationwide Children's Hospital
  888. The Aeras Global TB Vaccine Foundation
  889. The Albert Ludwig University of Freiburg
  890. The American Foundation for Biological Research (AFBR)
  891. The Arizona Board of Regents
  892. The Australian National University
  893. The Austrian Centre of Industrial Biotechnology (ACIB)
  894. The Autonomous University of Barcelona
  895. The Autonomous University of Madrid
  896. The Board Of Trustees Of The Leland Stanford Junior University
  897. The Board of Trustees of The University of Alabama 
  898. The Carlo Besta Neurological Institute
  899. The Catholic University of America
  900. The Catholic University Of Korea Industry-Academic Cooperation
  901. The Catholic University of Korea Industry-Academy Foundation
  902. The Center Hospitalier Universitaire de Lille
  903. The Centre for Genomic Regulation (CRG)
  904. The Centre Hospitalier Universitaire Sainte-Justine
  905. The Chancellor Masters & Scholars of The University of Oxford 
  906. The Charité – Universitätsmedizin Berlin
  907. The CHDI Foundation
  908. The Children's Medical Center
  909. The Cleveland Clinic Foundation
  910. The Collaborative Group
  911. The Connecticut Children's Medical Center
  912. The Cyprus Foundation for Muscular Dystrophy Research
  913. The Development Research Foundation (DRF)
  914. The Federal University of Rio de Janeiro
  915. The Federal University of Rio Grande do Sul
  916. The Federal University of Santa Maria 
  917. The Flanders Interuniversity Institute for Biotechnology
  918. The Fondazione Centro San Raffaele
  919. The French National Centre for Scientific Research
  920. The General Hospital Corporation
  921. The Geneva University Hospitals
  922. The Georg August University of Göttingen
  923. The Heinrich Pette Institute
  924. The Helmholtz Centre for Infection Research
  925. The Henry M. Jackson Foundation for the Advancement of Military Medicine
  926. The Idaho Research Foundation
  927. The Immune Response Corporation 
  928. The Indiana University Foundation
  929. The Indiana University Research and Technology Corporation
  930. The Industry-University-Research Cooperation Foundation
  931. The Institute for Research in Biomedicine (IRB Barcelona)
  932. The Institute of Cancer Research
  933. The International Centre for Genetic Engineering and Biotechnology
  934. The Iowa State University Research Foundation
  935. The Istituto Italiano di Tecnologia (IIT)
  936. The J.David Gladstone Institutes
  937. The Jawaharlal Nehru Centre for Advanced Scientific Research
  938. The Johns Hopkins University
  939. The Julius Maximilian University of Würzburg
  940. The Kaohsiung Medical University
  941. The Korea Research Institute of Bioscience and Biotechnology
  942. The Kyungpook National University, Industry & Academy Collaboration Foundation
  943. The Leland Stanford Junior University
  944. The LMU Klinikum
  945. The Marie Curie Research Institute
  946. The Mayo Foundation for Medical Education and Research
  947. The Medical College of Wisconsin
  948. The Medical School at University of Michigan--Ann Arbor
  949. The Medical University of Graz
  950. The Medical University of Vienna
  951. The Microbial Chemistry Research Foundation (MCRF)
  952. The Mount Sinai Health System
  953. The National Institute for Biotechnology in the Negev
  954. The National Research Council Canada 
  955. The National University of Ireland Galway
  956. The National University of Singapore
  957. The Nemours Foundation
  958. The New Hope Research Foundation
  959. The New York Genome Center (NYGC)
  960. The New York Stem Cell Foundation Research Institute
  961. The Novartis Institutes for BioMedical Research (NIBR)
  962. The Ohio State Innovation Foundation
  963. The Ohio State University
  964. The Ohio State University Research Foundation
  965. The Oklahoma Medical Research Foundation (OMRF)
  966. The Penn State Research Foundation 
  967. The Picower Institute for Learning and Memory
  968. The Queen's University of Belfast
  969. The Regents of the University of Michigan
  970. The Research Foundation for the State University of New York
  971. The Rockefeller University
  972. The Rudolf Magnus Institute for Neuroscience 
  973. The Ruhr University Bochum
  974. The Ruprecht Karl University of Heidelberg
  975. The San Diego State University Research Foundation
  976. The Santa Lucia Foundation
  977. The Sapienza University of Rome
  978. The Scripps Research Institute
  979. The Seoul National University Foundation
  980. The Sloan Kettering Institute
  981. The Sogang University Research Foundation
  982. The Southern Illinois University Board of Trustees
  983. The Sungkyunkwan University Research & Business Foundation
  984. The Sydney Children's Hospitals Network (Randwick and Westmead)
  985. The Technical University of Munich
  986. The Technion Research & Development Foundation
  987. The Texas A&M System 
  988. The Trustees of The University of Pennsylvania
  989. The UAB Research Foundation
  990. The Université de Montréal
  991. The Université d'Évry Val-d'Essonne
  992. The Université Grenoble Alpes
  993. The Université libre de Bruxelles
  994. The University Health Network (UHN)
  995. The University Medical Center Hamburg-Eppendorf
  996. The University Medical Center Utrecht
  997. The University of Aberdeen
  998. The University of Alabama
  999. The University of Alberta
  1000. The University of Amsterdam
  1001. The University of Antwerp
  1002. The University of Arizona
  1003. The University of Arkansas
  1004. The University of Barcelona 
  1005. The University of Bari Aldo Moro
  1006. The University of Basel
  1007. The University of Beira Interior
  1008. The University of Bern
  1009. The University of Birmingham
  1010. The University of Bologna
  1011. The University of Bristol 
  1012. The University of British Columbia
  1013. The University of California
  1014. The University of Canberra
  1015. The University of Castilla–La Mancha
  1016. The University of Chicago
  1017. The University of Chile.
  1018. The University of Cincinnati
  1019. The University of Coimbra
  1020. The University of Cologne
  1021. The University of Colorado
  1022. The University of Connecticut
  1023. The University of Copenhagen
  1024. The University of Dublin
  1025. The University of Dundee
  1026. The University of Edinburgh
  1027. The University of Evry - Val-d'Essonne
  1028. The University of Ferrara
  1029. The University of Florida
  1030. The University of Florida Research Foundation
  1031. The University of Geneva
  1032. The University of Georgia
  1033. The University of Glasgow
  1034. The University of Granada
  1035. The University of Guelph
  1036. The University of Helsinki
  1037. The University of Hong Kong
  1038. The University of Houston
  1039. The University of Illinois Board of Trustees 
  1040. The University of Iowa Research Foundation (UIRF)
  1041. The University of Jaén
  1042. The University of Kansas
  1043. The University of Kentucky Research Foundation (UKRF)
  1044. The University of Lausanne
  1045. The University of Leeds
  1046. The University of Lincoln
  1047. The University of London
  1048. The University of Manchester
  1049. The University of Manitoba 
  1050. The University of Maryland
  1051. The University of Maryland Biotechnology Institute
  1052. The University of Massachusetts
  1053. The University of Miami
  1054. The University of Michigan
  1055. The University of Milan
  1056. The University of Milano-Bicocca
  1057. The University of Minnesota
  1058. The University of Missouri
  1059. The University of Montpellier
  1060. The University of Münster
  1061. The University of Nantes
  1062. The University of Natural Resources and Life Sciences
  1063. The University of Nebraska–Lincoln
  1064. The University of Nevada, Las Vegas
  1065. The University of New Mexico
  1066. The University of New South Wales
  1067. The University of Nice Sophia Antipolis
  1068. The University of North Carolina at Chapel Hill 
  1069. The University of Notre Dame
  1070. The University of Nottingham
  1071. The University of Oklahoma
  1072. The University of Orléans
  1073. The University of Otago
  1074. The University of Ottawa
  1075. The University of Padua
  1076. The University of Paris 
  1077. The University of Pennsylvania
  1078. The University of Pittsburgh 
  1079. The University of Plymouth
  1080. The University of Pretoria
  1081. The University of Putra Malaysia
  1082. The University of Rochester 
  1083. The University of Rostock
  1084. The University of Santiago de Compostela
  1085. The University of Saskatchewan
  1086. The University of Sheffield
  1087. The University of Siena 
  1088. The University of South Alabama
  1089. The University of South Australia
  1090. The University of South Carolina
  1091. The University of South Florida 
  1092. The University of Southampton
  1093. The University of Southern California
  1094. The University of Strasbourg
  1095. The University of Sydney
  1096. The University of Szeged
  1097. The University of Tartu
  1098. The University of Tennessee Research Foundation
  1099. The University of Texas
  1100. The University of Texas System Board of Regents
  1101. The University of the Basque Country
  1102. The University of the Mediterranean Aix-Marseille II
  1103. The University Of Toronto Governing Council 
  1104. The University of Ulsan
  1105. The University of Ulster
  1106. The University of Utah
  1107. The University of Vermont and State Agricultural College
  1108. The University of Verona
  1109. The University of Veterinary Medicine Vienna
  1110. The University of Vienna
  1111. The University of Virginia
  1112. The University of Warwick
  1113. The University of Washington
  1114. The University of Western Australia
  1115. The University of Wroclaw
  1116. The University of Wyoming
  1117. The University of Zurich
  1118. The Vaud University Hospital Center (CHUV)
  1119. The Wellcome Trust
  1120. The Wisconsin Alumni Research Foundation
  1121. The Yonsei University Office of Research Affair
  1122. Theragene Biomedical Lab
  1123. TheraPten Biosciences
  1124. Therion Biologics
  1125. Thomas Jefferson University
  1126. Titan Pharmaceuticals
  1127. TLL Temasek Life Sciences Laboratory
  1128. Tocagen
  1129. Tokai National Higher Education and Research System National University Corporation 
  1130. Tokyo Metropolitan Institute of Medical Science
  1131. Tongji University
  1132. ToolGen
  1133. Toppan
  1134. Toray Research Center
  1135. Torque Therapeutics
  1136. Transderm
  1137. TransGenRx
  1138. Transkaryotic Therapies
  1139. Tranzyme
  1140. TremRx
  1141. TRIM-edicine
  1142. TSI
  1143. Tufts University
  1144. Tuskegee University
  1145. UCB Biopharma
  1146. Ulsan National Institute of Science and Technology
  1147. Ultragenyx
  1148. UMIP The University of Manchester Intellectual Property
  1149. Umoja Biopharma
  1150. Unicyte
  1151. UniQure Biopharma
  1152. Université Lille 2 Droit et Santé
  1153. University College London Business
  1154. University Court of the University of Edinburgh
  1155. University of Artois
  1156. University of Cambridge School of Technology
  1157. University Of Florida Research Foundation
  1158. University of Massachusetts Medical School
  1159. University of Patras
  1160. University of Pittsburgh - of the Commonwealth System of Higher Education
  1161. University of Primorska
  1162. University of Tennessee Research Foundation
  1163. University of Virginia Patent Foundation
  1164. University of Western Brittany
  1165. Utah State University
  1166. Vacdiagn Biotechnology
  1167. Valentis
  1168. Vanderbilt University
  1169. Vascular Biogenics
  1170. Vaxart
  1171. Vaxbio
  1172. VaxCell
  1173. Vecprobio
  1174. Vectogen
  1175. VectorLogics
  1176. Vegenics 
  1177. Verenium
  1178. Versailles Saint-Quentin-en-Yvelines University 
  1179. Versameb
  1180. VersiTech
  1181. Vertex Pharmaceuticals
  1182. VGX Pharmaceuticals
  1183. Viagene
  1184. Vical
  1185. Viela Bio
  1186. Vir Biotechnology
  1187. Viragen
  1188. Virginia Commonwealth University
  1189. Virogin Biotech
  1190. ViroLogic
  1191. ViroMed
  1192. Viron Therapeutics
  1193. Virovek
  1194. Virus Ikagaku Kenkyusho
  1195. VIRxSYS
  1196. Vision 7
  1197. Vlaams Institute for Biotechnology
  1198. Voyager Therapeutics
  1199. Vrije Universiteit Brussel (VUB)
  1200. Vycellix
  1201. Wake Forest University
  1202. Wayne State University
  1203. Wellstat Biologics
  1204. Wellstat Ophthalmics
  1205. Westlake Therapeutics
  1206. Whitehead Institute for Biomedical Research
  1207. William Marsh Rice University
  1208. Wuhan Institute of Physics and Mathematics of Chineses Academy of Science
  1209. WuXi Biologics
  1210. Wyeth
  1211. Xalud Therapeutics
  1212. Xencor
  1213. Xenetic Biosciences
  1214. Xiamen University Malaysia
  1215. Xiangue Life Sciences
  1216. Xuanwu Hospital affiliated to Capital Medical University
  1217. XyloCor Therapeutics
  1218. Yale University
  1219. Yang Sheng Tang Group
  1220. Yissum Research Development Company of the Hebrew University of Jerusalem
  1221. Yokohama City University
  1222. Yongxin Biological Science And Technology
  1223. Yonsei University
  1224. Youhealth Biotech
  1225. Zaklady Farmaceutyczne Polpharma
  1226. Zengen
  1227. Zensun Science & Technology
  1228. Zentrum für Forschungsförderung in der Pädiatrie
  1229. Zhejiang University
  1230. Zhengzhou University
  1231. Zycos

PRICING DETAILS

USD 1,299

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 8) n a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com